Safety and efficacy of injection of human placenta mesenchymal stem cells derived exosomes for treatment of complex perianal fistula in non‐Crohn's cases: Clinical trial phase I
Journal of Gastroenterology and Hepatology · 2023-04 · 38 (4) · 539-547
DOI: 10.1111/jgh.16110 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 02.02.2023. Verfasst von Haleh Pak und 12 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal Research Center, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Crohn Disease, Exosomes, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background and Aim A perianal fistula is an abnormal tract that connects anal canal to skin. Current medical and surgical interventions have a high failure rate particularly in complex and refractory cases. MSC‐derived exosomes have demonstrated immunomodulatory effects without the conventional complications; hence, in this study, we evaluated the safety of their application for complex perianal fistula.
Methods
Placenta‐derived MSCs were cultured, and exosomes were isolated using ultracentrifugation. Exosome injections were administered in the operating room to 11 patients with complex perianal fistula (presence of fistulas for at least 1 year alongside medical and surgical treatment). The patients were followed for 6 months, and the patients were evaluated using physical examination, face‐to‐face interviews, and magnetic resonance imaging (MRI).
Results
Among 11 patients only one did not show any improvement upon physical examination. Five patients showed complete tract resolve. While the discharge was stopped in eight patients, two patients showed only reduction. None of the patients showed any acute or latent allergic reaction or injection related complications.
Conclusion
Administration of exosomes isolated from MSCs demonstrates safety and a satisfactory therapeutic effect in treatment complex perianal fistulae; therefore, it can be a candidate for future studies and might play a significant role in treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Colorectal Research Center, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
- Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Cell Therapy and Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
- Division of Colorectal Surgery, Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Radiology, Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran.
- Department of radiology, Isfahan university of medical sciences, Isfahan, Iran.
ORCID-Profile: Alireza Hadizadeh, Seyed Mohsen Ahmadi Tafti
Zitieren
APA
Pak, H., Hadizadeh, A., Heirani-Tabasi, A., Soleimani, M., Asbagh, R. A., Fazeli, M. S., Kazemeini, A., Keshvari, A., Keramati, M. R., Salahshour, F., Nazari, H., Tafti, S. M. A., & Behboudi, B. (2023). Safety and efficacy of injection of human placenta mesenchymal stem cells derived exosomes for treatment of complex perianal fistula in non‐Crohn's cases: Clinical trial phase I. Journal of Gastroenterology and Hepatology, 38(4), 539-547. https://doi.org/10.1111/jgh.16110
Vancouver
Pak H, Hadizadeh A, Heirani-Tabasi A, Soleimani M, Asbagh RA, Fazeli MS, et al. Safety and efficacy of injection of human placenta mesenchymal stem cells derived exosomes for treatment of complex perianal fistula in non‐Crohn's cases: Clinical trial phase I. Journal of Gastroenterology and Hepatology. 2023;38(4):539-547. doi:10.1111/jgh.16110
BibTeX
@article{Pak2023,
author = {Pak, Haleh and Hadizadeh, Alireza and Heirani-Tabasi, Asieh and Soleimani, Masoud and Asbagh, Reza Akbari and Fazeli, Mohammad Sadegh and Kazemeini, Alireza and Keshvari, Amir and Keramati, Mohammad Reza and Salahshour, Faezeh and Nazari, Hengameh and Tafti, Seyed Mohsen Ahmadi and Behboudi, Behnam},
title = {Safety and efficacy of injection of human placenta mesenchymal stem cells derived exosomes for treatment of complex perianal fistula in non‐Crohn's cases: Clinical trial phase I},
journal = {Journal of Gastroenterology and Hepatology},
year = {2023},
volume = {38},
number = {4},
pages = {539--547},
doi = {10.1111/jgh.16110}
}
EUVIMED